The changing landscape of acromegaly – an epidemiological perspective-Reference-Cited by-同舟云学术

The changing landscape of acromegaly – an epidemiological perspective

Published:2024-02-10 Issue:4 Volume:25 Page:691-705
ISSN:1389-9155
Container-title:Reviews in Endocrine and Metabolic Disorders
language:en
Short-container-title:Rev Endocr Metab Disord

Author:

Rosendal Christian^ORCID,Arlien-Søborg Mai Christiansen^ORCID,Nielsen Eigil Husted^ORCID,Andersen Marianne Skovsager^ORCID,Feltoft Claus Larsen,Kistorp Caroline^ORCID,Dekkers Olaf M.^ORCID,Jørgensen Jens Otto Lunde^ORCID,Dal Jakob^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11154-024-09875-z.pdf

Reference102 articles.

1. Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S. Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 2022;10:804–26. https://doi.org/10.1016/S2213-8587(22)00244-3.

2. Dal J, Feldt-Rasmussen U, Andersen M, Kristensen L, Laurberg P, Pedersen L, et al. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol. 2016;175:181–90. https://doi.org/10.1530/EJE-16-0117.

3. Esposito D, Ragnarsson O, Johannsson G, Olsson DS. Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol. 2020;182:523–31. https://doi.org/10.1530/EJE-20-0019.

4. Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, et al. Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database. Endocr Relat Cancer. 2017;24:505–18. https://doi.org/10.1530/ERC-17-0253.

5. Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B, et al. Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study. Endocrine. 2019;63:120–9. https://doi.org/10.1007/S12020-018-1764-4.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies;High Blood Pressure & Cardiovascular Prevention;2024-09-07

2. Growth hormone receptor antagonist pegvisomant and its role in the medical therapy of growth hormone excess;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

3. Cardiac MRI in acromegaly: looking for a big heart;Pituitary;2024-06-28

4. Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study;Frontiers in Endocrinology;2024-04-04